| |
|
富野 康日己 |
医療法人社団松和会 理事長
|
| 腎臓内科学 |
| “Novel coronavirus disease in patients with end-stage kidney disease” Noriaki Shimada, Hiroaki Shimada, Yoshiaki Itaya, Yasuhiko Tomino. Therapeutic Apheresis and Dialysis 11 October 2020 DOI: 10.1111/1744-9987.13599
|
“Recent Understanding of Peritoneal Pathology in Peritoneal Dialysis Patients in Japan” Chieko Hamada, Yasuhiko Tomino.
Blood Purification, 2021 Feb 10; 1-10 DOI: 10.1159/000510282
|
“Relationship among Left Ventricular Hypertrophy, Cardiovascular
Events, and Preferred Blood Pressure Measurement Timing in
Hemodialysis Patients” Hiroaki Io, Junichiro Nakata, Hiroyuki
Inoshita, Masanori Ishizaka, Yasuhiko Tomino and Yusuke Suzuki.
J. Clin. Med. 2020, 9, 3512; October 30, 2020
DOI: 10.3390/jcm9113512
|
|
| |
|
佐々木 成 |
特定医療法人社団清湘会・理事長
東京医科歯科大学・名誉教授
|
| 腎臓内科学 |
| Phosphorylation profile of human AQP2 in urinary exosomes by LC-MS/MS phosphoproteomic analysis. Sakai M, Yamamoto K, Mizumura H, Matsumoto T, Tanaka Y, Noda Y, Ishibashi K, Yamamoto T, Sasaki S. Clin Exp Nephrol. 24: 762-769, 2020
|
| Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study. Iimori S, Naito S, Noda Y, Sasaki S et al. Nephrology 20: 601-608, 2015
|
| Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2. Sasaki S, Chiga M, Kikuchi E, et al. Clin Exp Nephrol. 17:338-344, 2013
|
|
| ○ |
|
菱田 明 |
浜松医科大学名誉教授
焼津市立総合病院・名誉院長
|
| 腎臓内科学 |
|
Optimal follow-up intervals for different stages of chronic kidney disease: a prospective observational study. Hirano K, Kobayashi D, Kohtani N, Uemura Y, Ohashi Y, Komatsu Y, Yanagita M, Hishida A. Clin Exp Nephrol. 23(5):613-620. 2019.
|
|
Cardiovascular events and death in Japanese patients with chronic kidney disease. Tanaka K, Watanabe T, Takeuchi A, Ohashi Y, Nitta K, Akizawa T, Matsuo S, Imai E, Makino H, Hishida A; CKD-JAC Investigators.
|
Kidney Int. 91:227-234.2017.
「保健指導で高血圧パラドックスの解消へ」菱田明他共著、東京医学社、（2020）
|
|
|
|
東原英二 |
杏林大学医学部遺伝性腎疾患研究講座特任教授
|
| 腎臓学 |
|
Imaging Identification of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease: Simple Eligibility Criterion for Tolvaptan. Eiji Higashihara, Shigeo Horie, Satoru Muto, Haruna Kawano, Mitsuhiro Tanbo, Tsuyoshi Yamaguchi, Satoru Taguchi, Shinya Kaname, Kenichi Tokoyama, Tatsuya Yoshioka, Toshihito Furukawa, Hiroshi Fukuhara. Am J Nephrol. 2020. 51: 881-890.
|
| Estimation of changes in kidney volume growth rate in autosomal dominant polycystic kidney disease. Eiji Higashihara, Hiroshi Fukuhara, John Ouyang, Jennifer Lee, Kikuo Nutahara, Mitsuhiro Tanbo, Tsuyoshi Yamaguchi, Satoru Taguchi, Satoshi Muto, Shinya Kaname, Isao Miyazaki, Shigeo Horie. Kidney Int Reports. 2020. 5: 1459-1471.
|
| PKD1-associated arachnoid cysts in autosomal dominant polycystic kidney disease. Shigemori K, Higashihara E, Itoh M, Yoshida H, Yamamoto K, Nutahara K, Shiokawa Y, Kaname S, Tambo M, Yamaguchi T, Taguchi S, Yoshioka T, Yokoyama K, Fukuhara H. J Stroke Cerebrovasc Dis, 2021. (September) 30 (9), https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105943
|
|
